Design of new, nonpeptide MMP inhibitors reported by Pharmacia & Upjohn at ACS meeting March 27, 2000
Dual ACAT-inhibitory/antioxidant effects of KY-455 may be advantageous in atherosclerosis March 27, 2000
Potent and selective PDE5 inhibitor may be useful in erectile dysfunction, heart failure March 27, 2000
Orally bioavailable gpIIb/IIIa receptor antagonist ME-3230 profiled at Japanese meeting March 27, 2000
Kotobuki's new hypouricemic agent KT-651 inhibits biosynthesis, enhances excretion of uric acid March 27, 2000
The novel antiarrhythmic agent NIP-142 may act by blocking open Kv1.5 potassium channels March 24, 2000
Neurotrophic and cognition-enhancing effects reported for TEI-3356 this week in Yokohama March 24, 2000
RSS